Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Ceftaroline Fosamil in Children
NCT01298843Phase 4Completed
- Sponsor
- Forest Laboratories
- Start
- Apr 2011
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ceftaroline fosamil in bacterial infection, sponsored by Forest Laboratories. Primary endpoints: Pharmacokinetic profile of Ceftaroline fosamil up to 5 days and Safety and tolerability of ceftaroline fosamil up to 5 days. Started Apr 2011; status: completed.
02
Drugs
ceftaroline fosamil
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT01298843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01298843.